Select a State

Global health R&D delivers for New Mexico

US government investment in global health R&D has delivered

$24.3 million
to New Mexico research institutions
250+ new jobs
for New Mexico

Neglected diseases in New Mexico

Chikungunya cases
5
Dengue cases
11
HIV diagnoses
1,257
Malaria cases
18
Tuberculosis cases
432
West Nile cases
174
Zika cases
10

New Mexico's top USG-funded global health R&D institutions

University of New Mexico
$18.4 million
Los Alamos Scientific Laboratory
$4.9 million
The National Center for Genome Resources
$497 thousand
Santa Fe Institute
$362 thousand
The Lovelace Respiratory Research Institute (including Lovelace Biomedical and Environmental Research)
$49 thousand

New Mexico industry in global health R&D

Agilvax
Location(s):
Albuquerque
Creative LIBS Solution
Location(s):
Bernalillo
Mesa Biotech
Location(s):
Santa Fe
VisionQuest Biomedical
Location(s):
Albuquerque

New Mexico's top areas of global health R&D by USG funding

21.8%
HIV/AIDS
12.5%
Malaria
24.7%
Tuberculosis
2.0%
Bacteria pneumonia & meningitis
36.8%
Neglected tropical diseases
Dengue
Helminths
Kinetoplastids
Trachoma
2.1%
Other
Diarrheal diseases
Ebola/viral hemorrhagic fevers

Global health R&D at work in New Mexico

University of New Mexico researchers have developed a rapid breath test to detect tuberculosis and other lung diseases, such as pneumonia. The noninvasive, easy-to-use test offers results in 10 minutes without need for expensive laboratory equipment. The test is a major step forward in terms of speed and portability. It will enable doctors in low-resource settings to quickly detect lung infections and get patients on treatment. The technology has led to the creation of a company headquartered in Santa Fe which plans to commercialize the test, highlighting the economic returns of global health research.

Footnotes